FMO5 and infection: SGLT-2i also mitigates oxidative stress and inflammation by modulating NADPH oxidases and protein kinase C, reducing reactive oxygen species and systemic inflammation, which benefits vascular stability and lowers infection risks in patients with T2DM [49,50,51].